Following on an approval from the USFDA, Gaithersburg, Maryland-based biotechnology company Novavax said that its Covid-19 vaccine Nuvaxovid for adults will be manufactured by its partner Serum Institute of India. (SII) "It is the first vaccine from India to be approved by the USFDA," Serum Institute’s CEO Adar Poonawalla, said....